StockData
Provectus Biopharmaceuticals, Inc. logo

Provectus Biopharmaceuticals, Inc. (PVCT) stock

PVCTOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 3/30
$0.05+0.00 (+0.39%)

Close on Oct 19, 2026Market cap $20.55MP/E –Yield –

Provectus Biopharmaceuticals statistics

27 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
–

Share statisticsIndustry

Shares Change (YoY)
-0.00%
10.8%
Shares Change (QoQ)
0.00%
0.49%
Float
334M
49M
Shares Held by Insiders
20.4%
11.6%
Shares Held by Institutions
0.03%
56.4%

Returns on capitalIndustry

Return on Assets (ROA)
-1060.7%
-40.6%

Financial positionIndustry

Current Ratio
0.05
3.30
Quick Ratio
0.03
2.39
Interest Coverage
-563.96
-6.31

GrowthIndustry

Revenue Growth (3Y CAGR)
-30.2%
2.25%

EfficiencyIndustry

Profits Per Employee
-$784.06K
-$690.06K
Employee Count
6
75

Income statement (TTM)Industry

Operating Income
-$4.52M
-$21.40M
Net Income
-$4.70M
-$22.39M
EBITDA
-$4.52M
-$17.04M
EPS (Diluted)
$0.00
-$0.76

Balance sheetIndustry

Net Cash (Debt)
$180.73K
$17.80M
Net Cash Per Share
$0.00
$0.80
Equity (Book Value)
-$6.66M
$53.27M
Book Value Per Share
-$0.02
$1.50
Tangible Book Value
-$6.66M
$26.82M
Working Capital
-$6.73M
$79.93M

Cash flow (TTM)Industry

Operating Cash Flow
-$2.44M
-$12.35M

Taxes and interestIndustry

Interest Expense
$8.01K
$2.93M

Scores and fair valueIndustry

Piotroski F-Score
1
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.

PeriodPVCTS&P 500DifferencePVCT per yearS&P 500 per year
1 month-11.1%+0.6%−11.7 pts
3 months-19.1%+3.4%−22.5 pts
Year to date-12.5%+13.3%−25.8 pts
1 year-35.0%+16.6%−51.6 pts
3 years-24.8%+86.4%−111.1 pts-9.1%+23.1%
5 years-19.8%+81.9%−101.7 pts-4.3%+12.7%
10 years+4.0%+318.9%−314.8 pts+0.4%+15.4%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

1M PVCT shares were sold short on Oct 30, 2026, up 0.0% from the previous report. At recent volumes it would take 4.6 days to buy them back.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 2026801,1740.0%175,1594.6
Oct 15, 2026801,1740.0%138,6975.8
Sep 30, 2026801,1740.0%166,3694.8
Sep 15, 2026801,174-0.1%175,5534.6
Aug 31, 2026802,0430.0%357,6862.2
Aug 14, 2026802,043+0.0%209,0403.8
Jul 31, 2026801,793-0.1%382,3702.1
Jul 15, 2026802,797+10237.3%544,6701.5
Jun 30, 20267,766-99.0%285,8141.0
Jun 15, 2026802,784+41110.7%182,6584.4
May 29, 20261,948-89.5%324,8281.0
May 15, 202618,505-97.7%318,1271.0

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?